2-(5-((3-amino-2-oxopyridin-1(2H)-yl)methyl)-4-(3-phenylpropyl)-4H-1,2,4-triazol-3-ylthio)-N-cyclopentylacetamide hydrochloride

ID: ALA4520417

PubChem CID: 155542209

Max Phase: Preclinical

Molecular Formula: C24H31ClN6O2S

Molecular Weight: 466.61

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cl.Nc1cccn(Cc2nnc(SCC(=O)NC3CCCC3)n2CCCc2ccccc2)c1=O

Standard InChI:  InChI=1S/C24H30N6O2S.ClH/c25-20-13-7-14-29(23(20)32)16-21-27-28-24(33-17-22(31)26-19-11-4-5-12-19)30(21)15-6-10-18-8-2-1-3-9-18;/h1-3,7-9,13-14,19H,4-6,10-12,15-17,25H2,(H,26,31);1H

Standard InChI Key:  GMJYJGZRPCJMAQ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 34 36  0  0  0  0  0  0  0  0999 V2000
    1.9446   -1.2670    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.8227   -2.4755    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0822   -3.2586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8902   -3.4254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2293   -4.1744    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0493   -4.0835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2161   -3.2754    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4992   -2.8672    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8211   -4.8914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2379   -5.6034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8297   -6.3204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2496   -7.0269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6049   -4.6933    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.4109   -4.5171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9665   -5.1270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7724   -4.9507    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7161   -5.9131    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.3281   -5.5606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8461   -7.7421    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2652   -8.4481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0878   -8.4382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4895   -7.7163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0681   -7.0133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1642   -6.3660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8811   -6.7743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4910   -6.2186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1509   -5.4670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3710   -1.8582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1144   -1.0779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3070   -0.9069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7565   -1.5225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0133   -2.3094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4639   -2.9249    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9490   -1.3530    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  4  2  0
  5  9  1  0
  9 10  1  0
 10 11  1  0
 12 11  1  0
  6 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 16 18  1  0
 12 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 12  1  0
 18 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 18  1  0
  2 28  1  0
  2 32  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 31 34  1  0
M  END

Associated Targets(Human)

RAD51 Tchem DNA repair protein RAD51 homolog 1 (504 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 466.61Molecular Weight (Monoisotopic): 466.2151AlogP: 2.85#Rotatable Bonds: 10
Polar Surface Area: 107.83Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.21CX LogP: 2.01CX LogD: 2.01
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.45Np Likeness Score: -1.92

References

1. Roberti M, Schipani F, Bagnolini G, Milano D, Giacomini E, Falchi F, Balboni A, Manerba M, Farabegoli F, De Franco F, Robertson J, Minucci S, Pallavicini I, Di Stefano G, Girotto S, Pellicciari R, Cavalli A..  (2019)  Rad51/BRCA2 disruptors inhibit homologous recombination and synergize with olaparib in pancreatic cancer cells.,  165  [PMID:30660828] [10.1016/j.ejmech.2019.01.008]

Source